Evidence map›Paper›PMID 41877135›Full record

ArticleBMC cancer2026

Efficiency and safety of a guidewire-less approach to superselective transarterial microcatheter procedures in hepatic cancer interventions.

Pi-Yi Chang, Wei-Ru Chiou

Abstract read
In one paragraph

Article in BMC cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Pi-Yi ChangDepartment of Medical Imaging, Taichung Veterans General Hospital, Taichung, 407, Taiwan.
Wei-Ru ChiouDivision of Cardiology, Taitung MacKay Memorial Hospital, Taitung, 950, Taiwan. clementchiou@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNo study of patients with hepatocellular carcinoma (HCC) has compared the procedure time of transcatheter arterial chemoembolization (TACE) using guidewire-less and guidewire techniques. The present study aimed to further compare the procedure time and radiation exposure of the “Wireless Angiographic VEssel Selection” (WAVES) technique, hybrid procedure and conventional guidewire TACE.

methodsProcedure time and radiation dose were compared between patients with HCC treated with the WAVES (n = 125) or conventional TACE (n = 59). Among WAVES group, 36 patients were switched to conventional procedure if the desired location could not be reached after 3 min of initiated WAVES procedure (hybrid group). In the per-treatment analysis, procedure and radiation dose were also compared between the 3 group.

resultsWAVES procedure (β = -13.694, 95% confidence interval [CI]: -18.215, -9.173, p < 0.001) was an independent predictor of shorter procedure time compared to a conventional procedure. A longer procedure time was an independent predictor of higher radiation dose (β = 14.216, 95% CI: 12.654, 15.777, p < 0.001). After stratifying for vessel type (moderate difficulty [MD] and high difficulty [HD]), an association between WAVES and shorter procedure time was also found in both MD (WAVES vs. conventional: β = -21.085, 95% CI: -28.799, -13.371, p < 0.001) and HD (WAVES vs. conventional: β = -10.784, 95% CI: -16.644, -4.924, p < 0.001) subgroups. An association between longer procedure time and higher radiation dose was also found in both MD (β = 14.938, 95% CI: 12.694, 17.183, p < 0.001) and HD (β = 13.617, 95% CI: 11.293, 15.942, p < 0.001) subgroups. In the per-treatment analysis, the similar associations between WAVES procedure and procedure time and radiation dose as compared to conventional procedure. In addition, hybrid procedure (β = -12.202, 95% CI: -17.697, -6.708, p < 0.001) was as an independent predictor of shorter procedure time compared to a conventional procedure. A longer procedure time was an independent predictor of higher radiation dose (β = 14.389, 95% CI: 12.962, 15.816, p < 0.001). After stratifying for vessel type, an association between hybrid procedure and shorter procedure time was only found in the MD subgroup (hybrid vs. conventional: β = -19.771, 95% CI: -34.280, -5.263, p = 0.009), but this association was not observed in the HD subgroup (hybrid vs. conventional: β = -6.595, 95% CI: -15.894, 2.705, p = 0.160). An association between longer procedure time and higher radiation dose was also found in both MD (β = 15.046, 95% CI: 13.097, 16.995, p < 0.001) and HD (β = 13.869, 95% CI: 11.719, 16.018, p < 0.001) subgroups.

conclusionThe use of WAVES or hybrid procedure is associated with shorter procedure duration in patients with HCC undergoing TACE, which reduces radiation dose. It may be deployed as a first-line approach for MD rather than HD vessels.

Indexed as

Carcinoma, HepatocellularChemoembolization, TherapeuticLiver NeoplasmsAgedFemaleHumansMaleMiddle AgedRadiation DosageRetrospective StudiesTreatment OutcomeGuidewire-lessHepatocellular carcinomaProcedure time-associated radiation doseTranscatheter Arterial Chemoembolization (TACE)

Identifiers

PMID41877135
PMCPMC13137538

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.